This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ross, A. M. Articles by Van de Werf, F. Search for Related Content PubMed Articles by Ross, A. M. Articles by Van de Werf, F. Related Collections Related Article

The Impact of Place of Enrollment and Delay to Reperfusion on 90-Day Post-Infarction Mortality in the ASSENT-4 PCI Trial

Assessment of the Safety and Efficacy of a New Treatment Strategy With Percutaneous Coronary Intervention

Allan M. Ross, MD^_*, Kurt Huber, MD, Uwe Zeymer, MD^,_*, Paul W. Armstrong, MD, Christopher B. Granger, MD^||, Patrick Goldstein, MD^¶, Kris Bogaerts, MD^#, Frans Van de Werf, MD^_**

^_* Department of Medicine, George Washington University, Washington, DC
Third Department of Medicine, Cardiology and Emergency Medicine, Wihelminenhospital, Vienna, Austria
Herzzentrum, Ludwigshafen, Germany
Department of Cardiology, University of Alberta, Edmonton, Alberta, Canada
^|| Duke Clinical Research Center, Durham, North Carolina
^¶ Hopital Lille, Lille, France
^# Statistical Center, University Hospital Gasthuisberg, Leuven, Belgium
^_** Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium

^_* Reprint requests and correspondence: Dr. Uwe Zeymer, Herzzentrum Ludwigshafen, Bremserstrasse 79, D-67063 Ludwigshafen, Germany (Email: Uwe.Zeymer{at}t-online.de).

Objectives: We have performed a retrospective analysis of the data stratified by time to treatment and by enrollment site: percutaneous coronary intervention hospitals (PCIH), nonpercutaneous coronary intervention hospitals (NoPCIH), or in a pre-hospital setting (PreH).

Background: The ASSENT-4 PCI (Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention) trial intended to test the hypothesis that in ST-segment elevation myocardial infarction (STEMI) patients an upfront fibrinolytic bolus before PCI ("facilitated PCI") compared with primary PCI would benefit STEMI patients facing a long pre-PCI delay.

Methods: Seven hundred forty-nine patients (45%) presented directly to PCIH, 578 (34%) presented to NoPCIH, and 334 (20%) were randomized and initially treated in the PreH setting.

Results: Patients in the PreH-facilitated group had the shortest delays (pain-to-fibrinolytic treatment 125 min) and the lowest 90-day mortality (3.1%). Among patients randomized to primary PCI, the shortest time from pain to first balloon was similarly in the PreH group (223 min). They had the lowest mortality of the primary PCI patient groups (4.1%). The highest mortality (8.4%) was in patients presenting to a PCIH and assigned to the facilitated strategy. Their pain-to-lysis time was 174 min and pain-to-PCI time 266 min (or 92 min after lysis).

Conclusions: Few patients fit the target population, long delays to PCI for whom facilitated PCI was designed. Patients treated early after pain onset in the PreH setting do well after a facilitated approach. Despite limitations of post hoc subgroup analysis, these observations suggest caution in extrapolating the results of the ASSENT-4 trial to the "real world" where many patients might have potentially short pain-to-fibrinolysis time but are facing a long transport time to primary PCI.

Key Words: facilitated PCI • reperfusion • STEMI

Abbreviations and Acronyms   NoPCIH = nonpercutaneous coronary intervention hospitals   PCI = percutaneous coronary intervention   PCIH = percutaneous coronary intervention hospitals   PreH = pre-hospital setting   STEMI = ST-segment elevation myocardial infarction

Related Article

The Ideal Reperfusion Strategy for the ST-Segment Elevation Myocardial Infarction Patient With Expected Delay to Percutaneous Coronary Intervention: Paradise Lost or Paradise Renamed?

Timothy D. Henry and David M. Larson
J. Am. Coll. Cardiol. Intv. 2009 2: 931-933. [Full Text] [PDF]

This article has been cited by other articles:

				A. E. Denktas, H. V. Anderson, J. McCarthy, and R. W. Smalling Total Ischemic Time: The Correct Focus of Attention for Optimal ST-Segment Elevation Myocardial Infarction Care J. Am. Coll. Cardiol. Intv., June 1, 2011; 4(6): 599 - 604. [Abstract] [Full Text] [PDF]

				H. Thiele, I. Eitel, C. Meinberg, S. Desch, A. Leuschner, D. Pfeiffer, A. Hartmann, U. Lotze, W. Strauss, G. Schuler, et al. Randomized Comparison of Pre-Hospital-Initiated Facilitated Percutaneous Coronary Intervention Versus Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction Very Early After Symptom Onset: The LIPSIA-STEMI Trial (Leipzig Immediate Prehospital Facilitated Angioplasty in ST-Segment Myocardial Infarction) J. Am. Coll. Cardiol. Intv., June 1, 2011; 4(6): 605 - 614. [Abstract] [Full Text] [PDF]

				T. D. Henry and D. M. Larson The Ideal Reperfusion Strategy for the ST-Segment Elevation Myocardial Infarction Patient With Expected Delay to Percutaneous Coronary Intervention: Paradise Lost or Paradise Renamed? J. Am. Coll. Cardiol. Intv., October 1, 2009; 2(10): 931 - 933. [Full Text] [PDF]